(Accessed 6 Oct 2018 )
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
Clinical trial transparency is important to participants, trialists, publishers, and regulators, and there have been recent major policy changes by the pharmaceutical industry regarding clinical study data sharing. However, it is unknown if these changes are enabling independent researchers to access participant-level data from prominent contemporary clinical trials sponsored by the pharmaceutical industry 2 years after publication of the primary results.
Authors: Ashley M. Hopkins, Andrew Rowland and Michael J. Sorich
Citation: BMC Medicine 2018 16:165
Published on: 28 September 2018